Sub Banner Image

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Market Impact

Avi Kapoor

·

July 25, 2025

·

Benzinga

Latest Ratings for EW

DateFirmActionFromTo
Feb 2022UBSUpgradesNeutralBuy
Jan 2022Morgan StanleyMaintainsOverweight
Jan 2022Raymond JamesMaintainsOutperform

View More Analyst Ratings for EW

View the Latest Analyst Ratings

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.